(S (PP (IN With) (NP (NP (DT the) (VBN increased) (NN affordability) (CC and) (NN availability)) (PP (IN of) (NP (JJ whole-genome) (NN sequencing))))) (, ,) (NP (ADJP (JJ large-scale) (CC and) (JJ high-throughput)) (NN gene) (NN expression)) (VP (VBZ is) (VP (ADVP (RB widely)) (VBN used) (S (VP (TO to) (VP (VB characterize) (NP (NP (NNS diseases)) (, ,) (PP (VBG including) (NP (NNS cancers))))))))) (. .))
(S (ADVP (RB However)) (, ,) (S (VP (VBG establishing) (NP (NN specificity)) (PP (IN in) (NP (NN cancer) (NN diagnosis))) (S (VP (VBG using) (NP (NN gene) (NN expression) (NNS data)))))) (VP (VBZ continues) (SBAR (SINV (S (VP (TO to) (VP (VB pose) (NP (NNS challenges))))) (PP (JJ due) (TO to) (NP (NP (DT the) (JJ high) (NN dimensionality) (CC and) (NN complexity)) (PP (IN of) (NP (DT the) (NNS data)))))))) (. .))
(S (ADVP (RB Here)) (NP (PRP we)) (VP (VP (JJ present) (NP (NP (NNS models)) (PP (IN of) (NP (NP (JJ deep) (NN learning)) (PRN (-LRB- -LRB-) (NP (NNP DL)) (-RRB- -RRB-)))))) (CC and) (VP (VB apply) (NP (PRP them)) (PP (TO to) (NP (NN gene) (NN expression) (NNS data))) (PP (IN for) (NP (NP (DT the) (NN diagnosis) (CC and) (NN categorization)) (PP (IN of) (NP (NN cancer))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN developed) (NP (CD two) (NNP DL) (NNS models)) (S (VP (VBG using) (NP (NP (NN messenger) (NN ribonucleic) (NN acid) (PRN (-LRB- -LRB-) (NN mRNA) (-RRB- -RRB-)) (VBZ datasets)) (ADJP (JJ available) (PP (IN from) (NP (DT the) (NNP Genomic) (NNP Data) (NNP Commons) (NN repository))))))))) (. .))
(S (NP (PRP$ Our) (NNS models)) (VP (VBN achieved) (NP (NP (ADJP (CD 98) (NN %)) (NN accuracy)) (PP (IN in) (NP (NN cancer) (NN detection)))) (, ,) (PP (IN with) (NP (NP (ADJP (ADJP (JJ false) (JJ negative)) (CC and) (ADJP (JJ false) (JJ positive))) (NNS rates)) (PP (IN below) (NP (CD 1.7) (NN %)))))) (. .))
(S (PP (IN In) (NP (PRP$ our) (NNS results))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (QP (CD 18) (IN out) (IN of) (CD 32)) (JJ cancer-typing) (NNS classifications)) (VP (VBD achieved) (NP (QP (JJR more) (IN than) (CD 90)) (NN %) (NN accuracy)))))) (. .))
(S (PP (JJ Due) (TO to) (NP (NP (DT the) (NN limitation)) (PP (IN of) (NP (NP (DT a) (JJ small) (NN sample) (NN size)) (PRN (-LRB- -LRB-) (NP (QP (JJR less) (IN than) (CD 50)) (NNS observations)) (-RRB- -RRB-)))))) (, ,) (NP (JJ certain) (NNS cancers)) (VP (VP (MD could) (RB not) (VP (VB achieve) (NP (DT a) (JJR higher) (NN accuracy)) (PP (IN in) (NP (VBG typing) (NN classification))))) (, ,) (CC but) (VP (ADVP (RB still)) (VBD achieved) (NP (JJ high) (NN accuracy)) (PP (IN for) (NP (DT the) (NN cancer) (NN detection) (NN task))))) (. .))
(S (S (VP (TO To) (VP (VB validate) (NP (PRP$ our) (NNS models))))) (, ,) (NP (PRP we)) (VP (VBN compared) (NP (PRP them)) (PP (IN with) (NP (JJ traditional) (JJ statistical) (NNS models)))) (. .))
(S (NP (NP (DT The) (JJ main) (NN advantage)) (PP (IN of) (NP (PRP$ our) (NNS models))) (PP (IN over) (NP (JJ traditional) (NN cancer) (NN detection)))) (VP (VBZ is) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB use) (NP (NP (NNS data)) (PP (IN from) (NP (JJ various) (NN cancer) (NNS types)))) (S (VP (TO to) (ADVP (RB automatically)) (VP (VB form) (NP (NP (NNS features)) (SBAR (S (VP (TO to) (VP (VB enhance) (NP (NP (DT the) (NN detection) (CC and) (NN diagnosis)) (PP (IN of) (NP (DT a) (JJ specific) (NN cancer) (NN type))))))))))))))))) (. .))
